No abstract available
MeSH terms
-
Clinical Trials as Topic / methods*
-
Diabetes Mellitus, Type 2 / drug therapy
-
Humans
-
Hypoglycemic Agents / adverse effects*
-
Hypoglycemic Agents / therapeutic use
-
Meta-Analysis as Topic
-
Myocardial Infarction / chemically induced*
-
Myocardial Infarction / mortality
-
Risk
-
Rosiglitazone
-
Thiazolidinediones / adverse effects*
-
Thiazolidinediones / therapeutic use
Substances
-
Hypoglycemic Agents
-
Thiazolidinediones
-
Rosiglitazone